Physician profile
Mariela Raquel Martinez-Rivera
NPI 1275080806
$104,892.13
in general payments reported to CMS, 2019-2025
8 companies · $101K in 2025
The $101K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $106 · 2024: $3,521 · 2025: $101K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $100K · Travel and Lodging: $2,748 · Food and Beverage: $1,877 · Education: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $100,000.00 |
| Travel and Lodging | $2,747.73 |
| Food and Beverage | $1,876.66 |
| Education | $267.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $102,976.47 | 2024-2025 | General - Erectile Dysfunction, General - Therapies, Ams 700 |
| Coloplast Corp | $1,526.61 | 2024-2025 | |
| Astrazeneca Pharmaceuticals Lp | $227.88 | 2023-2024 | Lynparza |
| Janssen Pharmaceuticals, INC | $81.04 | 2025 | Balversa, Erleada |
| Becton, Dickinson and Company | $24.60 | 2025 | Bard Inlay Optima Ureteral Stent With Hydroglide Guidewire |
| Pbg Puerto Rico LLC | $19.26 | 2025 | |
| Atricure, INC. | $19.15 | 2024 | |
| Medtronic, INC. | $17.12 | 2025 | Interstim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariela Martinez-Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.